Cva Family Office, LLC Ptc Therapeutics, Inc. Transaction History
Cva Family Office, LLC
- $634 Million
- Q1 2025
A detailed history of Cva Family Office, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 17 shares of PTCT stock, worth $691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 17
-0.0%
Holding current value
$691
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
270Shares Held
72.6MCall Options Held
180KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA8.61MShares$350 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$301 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$259 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$134 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.91B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...